Select text to enable text to speech.

Observational study

The Restore Vision team is working to better understand a group of seven rare eye diseases (REDs) and to help develop future treatments that might benefit patients.

To do this, we are running a non-interventional observational study. This means we do not give any treatment or test medicines – we simply collect data and samples. We investigate specific biological markers in these samples to inform us better about these REDs.

You can participate in the following countries

Italy Italy
France France
Germany Germany

Aniridia-associated keratopathy

Italy

4 / 5 patients included

France

0 / 15 patients included

Ocular Cicatricial Pemphigoid

Italy

7 / 10 patients included

France

0 / 10 patients included

Germany

0 / 3 patients included

Ectrodactyly-ectodermal dysplasia-clefting syndrome (EEC)

Italy

0 / 1 patients included

France

0 / 10 patients included

Neurotrophic Keratopathy

Italy

4 / 5 patients included

France

0 / 5 patients included

Germany

0 / 5 patients included

Limbal Stem Cell Deficiency

Italy

3 / 10 patients included

France

0 / 5 patients included

Germany

0 / 5 patients included

Ocular Graft versus Host Disease

Italy

14 / 15 patients included

France

0 / 5 patients included

Corneal Neovascularisation

Italy

7 / 10 patients included

France

0 / 5 patients included

Germany

0 / 5 patients included

Which conditions are being studied?

We are inviting patients diagnosed with one of the following conditions:

  Aniridia-Associated Keratopathy (AAK)

  Ocular Cicatricial Pemphigoid (OCP)

  Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome (EEC)

  Neurotrophic Keratopathy (NK)

  Limbal Stem Cell Deficiency (LSCD)

  Ocular Graft versus Host Disease (oGvHD)

  Corneal Neovascularisation (CNV)

Screenshot 2025-09-23 110658

Our goals are to:

1

Better understand how these rare diseases develop

2

Identify shared disease mechanisms among the 7 REDs

3

Discover new potential drug targets and support the development of future treatments

Goals 2

Frequently Asked Questions

In this study, we collect small samples such as blood, tear fluid, and surface eye cells. We analyse these to study proteins, genes, and other biological markers linked to these rare diseases. In addition, we record clinical parameters to check their correlation with the biological markers and check if there is a difference between people that have these REDs and those that do not.

Most rare eye diseases do not receive enough research funding and are not well understood, and current treatment options are limited. This study is a critical step toward changing that. By observing samples and data from people who have these REDS and those that do not we hope to uncover what’s really happening at a biological level. The more we understand about what causes these conditions, the closer we get to finding effective ways to slow, stop, or even treat these conditions.

  • Adults (18+) diagnosed with one of the seven conditions above
  • You can still take part if you have other conditions like myopia, as long as you meet the study criteria.
  • For the control population we are looking for adults (18+) who have not been diagnosed with one of the seven conditions above
  • Are pregnant or breastfeeding
  • Have an active eye infection or corneal perforation
  • Had eye surgery in the last 3 months
  • Changed your eye medication in the last month

If you take part, you’ll receive a free, full eye examination, followed by:

  1. A blood sample (no fasting needed)
  2. Tear collection using a small sponge under your eyelid
  3. A gentle eye surface test using a soft membrane for about 20 seconds (impression cytology)
  4. A short interview about your medical history and general health

The visit will last a couple of hours. More details are available in the individual study leaflets.

Please note: This study does not involve treatment – it is for research purposes only.

You can take part at one of our clinical sites:

  • Italy – Ospedale San Raffaele (OSR), Milan
    Contact: Silvia Palombella – palombella.silvia@hsr.it
  • France – INSERM (INS), Paris (starting soon)
  • Germany – University of Cologne (UKK) Contact Augenklinik Studien – augenklinik-studien@uk-koeln.de

All samples and personal information are:

  • Handled confidentially and securely. All personal data will be pseudonymised — meaning your identity will be protected by a code, and data will not be directly linked to you.
  • Used only for research within the Restore Vision project
  • Securely stored in the OSR biobank
  • Analysed at OSR’s lab and

We follow shared research protocols to ensure safety, high-quality data, and patient protection.

Watch the observational study at UKK in Germany:

Watch the observational study at OSR in Italy:

Where is the study happening?

Contact:

Silvia Palombella palombella.silvia@hsr.it

Contact

Contact:

Contact details will follow

Contact:

Augenklinik Studien augenklinik-studien@uk-koeln.de

Contact

Interested in participating?

The study will continue throughout 2025 and 2026.

If you would like to participate or have questions, please contact the clinic nearest you (see above).
We would be happy to share more information.